Skip to main content
Journal cover image

Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and Predictors of Success.

Publication ,  Journal Article
Benvenuti, TA; Chisholm, M; Cline, B; Johnson, DY; Befera, NT; Mastria, EM; Martin, JG; Ronald, J; Pabon-Ramos, W; Suhocki, PV; Smith, TP; Kim, CY
Published in: J Vasc Interv Radiol
October 2025

PURPOSE: To confirm the safety and modest effectiveness of provocative mesenteric angiography (PMA) in patients with occult gastrointestinal hemorrhage and identify predictors of success. MATERIALS AND METHODS: Retrospective review was performed on 119 provocative mesenteric angiograms on 109 patients (males, 73; mean age, 67.6 years; range, 7-94 years) over a 22-year period. PMA was defined as transcatheter administration of tissue plasminogen activator (tPA) into mesenteric arteries. Clinical, radiologic, and laboratory notes were reviewed. Adverse event rates within 30 days of the procedure were assessed. RESULTS: Of 119 provocative mesenteric angiograms, active extravasation was induced in 33 (27.7%) of procedures. On univariable analysis, older age, admission for acute gastrointestinal bleeding (GIB), hematochezia, prior positive radiologic study for GIB, transfusion of 2 or more units of blood, estimated nitroglycerin concentration ratio, estimated tPA concentration ratio, and increasing vessel selectivity for tPA administration were significant predictors of positive PMA (P < .05 for each). However, on multivariable analysis, only hematochezia (P = .036) and prior positive radiologic study (P = .016) were significant predictors of positive PMA. No patients with melena and negative radiologic studies had a positive PMA. No major bleeding adverse events occurred. CONCLUSIONS: PMA yielded a modest 27.3% positivity rate without clinically significant hemorrhagic adverse events. Prior positive radiologic studies for GIB and character of stool (melena vs hematochezia) significantly predicted provocation of bleeding. PMA is not recommended for patients with melena and negative radiologic imaging studies.

Duke Scholars

Published In

J Vasc Interv Radiol

DOI

EISSN

1535-7732

Publication Date

October 2025

Volume

36

Issue

10

Start / End Page

1558 / 1566

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Risk Factors
  • Retrospective Studies
  • Predictive Value of Tests
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Mesenteric Arteries
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Benvenuti, T. A., Chisholm, M., Cline, B., Johnson, D. Y., Befera, N. T., Mastria, E. M., … Kim, C. Y. (2025). Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and Predictors of Success. J Vasc Interv Radiol, 36(10), 1558–1566. https://doi.org/10.1016/j.jvir.2025.06.022
Benvenuti, Teresa A., Miriam Chisholm, Brendan Cline, David Y. Johnson, Nicholas T. Befera, Eric M. Mastria, Jonathan G. Martin, et al. “Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and Predictors of Success.J Vasc Interv Radiol 36, no. 10 (October 2025): 1558–66. https://doi.org/10.1016/j.jvir.2025.06.022.
Benvenuti TA, Chisholm M, Cline B, Johnson DY, Befera NT, Mastria EM, et al. Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and Predictors of Success. J Vasc Interv Radiol. 2025 Oct;36(10):1558–66.
Benvenuti, Teresa A., et al. “Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and Predictors of Success.J Vasc Interv Radiol, vol. 36, no. 10, Oct. 2025, pp. 1558–66. Pubmed, doi:10.1016/j.jvir.2025.06.022.
Benvenuti TA, Chisholm M, Cline B, Johnson DY, Befera NT, Mastria EM, Martin JG, Ronald J, Pabon-Ramos W, Suhocki PV, Smith TP, Kim CY. Provocative Mesenteric Angiography for Obscure Gastrointestinal Hemorrhage: An Update on Outcomes, Safety, and Predictors of Success. J Vasc Interv Radiol. 2025 Oct;36(10):1558–1566.
Journal cover image

Published In

J Vasc Interv Radiol

DOI

EISSN

1535-7732

Publication Date

October 2025

Volume

36

Issue

10

Start / End Page

1558 / 1566

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Risk Factors
  • Retrospective Studies
  • Predictive Value of Tests
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Mesenteric Arteries
  • Male